Catalog No.
DVV03006
Expression system
Mammalian Cells
Species reactivity
Hepatitis B virus genotype A2 subtype adw (isolate Japan/Nishioka/1983) (HBV-A)
Host species
Human
Isotype
IgG1-lambda
Clonality
Monoclonal
Target
Large envelope protein, L glycoprotein, L-HBsAg, LHB, Large S protein, Large surface protein, Major surface antigen, S
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P03142
Applications
Research Grade Biosimilar
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names
OST 577, OST577, OST-577
Clone ID
OST 577
Note
For research use only. Not suitable for clinical or therapeutic use.
Automated and combined HIV, HBV, HCV, and syphilis testing among illegal gold miners in French Guiana using a standardized dried blood device., PMID:36395882
Insights on 21 Years of HBV Surveillance in Blood Donors in France., PMID:36423116
Diagnostic performances of Exacto® Triplex rapid test for diagnosis of HIV/HCV/HBsAg: a multicenter, cross-sectional, field study in the Central African Republic., PMID:36451724
Evaluation of factors associated the expression of anti-HBs in children in Hunan Province, China., PMID:36471266
Hepatitis B burden and population immunity in a high endemicity city - a geographically random household epidemiology study for evaluating achievability of elimination., PMID:36628568
Seroepidemiology of HBV, HCV, HIV, HTLV, and CMV in Pregnant Women Referring to Sari Birth Cohort., PMID:36660762
Efficient stabilization of therapeutic hepatitis B vaccine components by amino-acid formulation maintains its potential to break immune tolerance., PMID:36714793
A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection., PMID:36748051
Low prevalence of hepatitis delta infection in Cuban HBsAg carriers: Prospect for elimination., PMID:36816726
Immunogenicity of Wild Type and Mutant Hepatitis B Surface Antigen Virus-like Particles (VLPs) in Mice with Pre-Existing Immunity against the Wild Type Vector., PMID:36851527
A simplified point-of-service model for hepatitis C in people who inject drugs in South Africa., PMID:36870990
Overall survival among patients who undergo resection does not differ significantly between T1a and T1b hepatocellular carcinoma based on the 8th American Joint Commission on Cancer., PMID:37103595
A Novel Insertion in the Hepatitis B Virus Surface Protein Leading to Hyperglycosylation Causes Diagnostic and Immune Escape., PMID:37112819
World Hepatitis day 2021 -screening and vaccination against Hepatitis B virus in Accra, Ghana., PMID:37328849
Novel anti‑hepatitis B virus flavonoids sakuranetin and velutin from Rhus retinorrhoea., PMID:37539729
Prevalence of hepatitis B and C viral co-infection and associated factors with HIV infection in children in South Kivu, Democratic Republic of the Congo., PMID:37580665
Ultrasensitive PCR system for HBV DNA detection: Risk stratification for occult hepatitis B virus infection in English blood donors., PMID:37796091
Living-donor lobar lung transplantation from a hepatitis B surface antigen-positive donor to a negative recipient., PMID:37816581
Successful results of early nucleos(t)ide analogue treatment for liver transplantation candidates with severe acute hepatitis B infection., PMID:37823433
Integrating viral hepatitis management into the emergency department: A further step towards viral hepatitis elimination., PMID:38074506
Anti-hepatitis C antibody carriage and risk of liver impairment in rural-Cameroon: adapting the control of hepatocellular carcinoma for resource-limited settings., PMID:38093205
Protection level of anti-hepatitis B vaccine and immunoglobulin in a pediatric Cameroonian population., PMID:38204806
Evaluation and experience from routine use of chemiluminescence assays for serological screening of blood and plasma donations on the Alinity s system and the Alinity i system, two new fully-automated immunoassay systems in Poland., PMID:38328514
An Anatomically Complicated Living Donor Kidney Transplantation from Hepatitis B Surface Antigen-Positive Donor to Negative Recipient With Size Discrepancy., PMID:38342747
Introducing adjuvant-loaded particulate hepatitis B core antigen as an alternative therapeutic hepatitis B vaccine component., PMID:38425450
Decentralised same day test and treatment of hepatitis C levering existing peer support networks among men who inject drugs: feasibility and effectiveness., PMID:38769517
Evaluation of a fully automated high-throughput serology assay for detection of Hepatitis D virus antibodies., PMID:38781633
Persistence and risk factors of occult hepatitis B virus infections among antiretroviral therapy-naïve people living with HIV in Botswana., PMID:38784816
Low Prevalence of Anti-HBc Antibody and Lack of HBV DNA Among HBsAg-Negative Blood Donors in Iran: A Cross-sectional Study and Review of Literature., PMID:38855800
Prevalence and risk factors of transmission of hepatitis delta virus in pregnant women in the Center Region of Cameroon., PMID:38900729
Effect of hepatitis B vaccination on HBV-infection among school children in Yaounde; ten years after the introduction of HBV vaccine into routine Immunization Program in Cameroon., PMID:39036018
The diagnostic cascade for patients with hepatitis delta infection in France, 2018-2022: A cross-sectional study., PMID:39115174
Assessing the diagnostic accuracy of serological tests for hepatitis delta virus diagnosis: a systematic review and meta-analysis., PMID:39122751
The Prevalence and Molecular Epidemiology of Hepatitis Delta Virus in Nigeria: The Results of a Nationwide Study., PMID:39205210
Safety of Hepatitis B Virus Screening in Blood Donors from the Hospital Foundation of Hematology and Hemotherapy of the State of Amazonas (HEMOAM) in the Brazilian Amazon., PMID:39459965
The PreS-Based Recombinant Vaccine VVX001 Induces Hepatitis B Virus Neutralizing Antibodies in a Low-Responder to HBsAg-Based HBV Vaccines., PMID:39460290
A three antigen hepatitis B vaccine induces T cells to Pres1 and Pres2 which correlate with anti HBs antibody titers: An investigation into the immunological mechanisms contributing to high anti-HBs titers., PMID:39536477
A novel method for recombinant mammalian-expressed S-HBsAg virus-like particle production for assembly status analysis and improved anti-HBs serology., PMID:39660966
Community prevalence of blood-borne viruses (hepatitis B and HIV) in Ireland., PMID:39847252
Prevalence and molecular characterization of hepatitis delta virus infection among hepatitis B virus surface antigen positive students and pregnant women in N'djamena, Chad., PMID:39895833
Detection of hepatitis B virus surface antigen, IgM and IgG antibodies to hepatitis B virus core antigen in the clinical classification and epidemiological surveillance of HBV infection., PMID:39903324
Screening for HBV, HCV, TP and HIV in pregnant women from various ethnic groups in Yili, Xinjiang, China., PMID:39923940
Hepatitis Delta and Liver Disease Among People Living With Hepatitis B With or Without HIV Co-Infection in Senegal., PMID:39967446
Potential role of liver-resident CD3+ macrophages in HBV clearance in a mouse hepatitis B model., PMID:40143948
A universal point-of-care immunochromatographic test for the serodiagnosis of hepatitis D., PMID:40214253
Auto-antibodies against interferons are common in people living with chronic hepatitis B virus infection and associate with PegIFNα non-response., PMID:40276479
Longstanding, undiagnosed, highly replicative hepatitis B virus reactivation in the presence of high levels of anti-HBs antibodies., PMID:40319465
Impact of the Hepatitis B Immunization Strategy Adopted in Italy from 1991: The Results of a Seroprevalence Study on the Adult Population of Florence, Italy., PMID:40333169
Hepatitis B and C Screening and Linkage to Care in Migrants From Endemic Countries in Barcelona Through a Community Action., PMID:40351294
Therapy with murinized tobevibart and elebsiran is efficacious in a liver-chimeric mouse model of HDV infection., PMID:40486136
For research use only. Not for human or drug use.
